Covid-19 Vaccine fiasco: Danger ahead

In this article for Signs of The Times, Robert Kennedy Jr. reports on the outcome of Moderna’s human trials. Citing a recent press release by the company, Kennedy highlights that three of the volunteers for the coronavaccine developed Grade 3 systemic events which is defined by the FDA as “preventing daily activity and requiring medical intervention”. Moreover, Kennedy said that Moderna’s Phase 1 findings only included reports for eight (out of the 15) participants.

Editor’s Note: In a previous article published in this website [see Is it possible to produce a COVID-19 vaccine in the next few months?] we already knew the dangers of cutting corners in vaccine development. This article is simply a confirmation of that knowledge [see 60+ Doctors And Educators Release Statement On The Situation Of Children And Adolescents During The 2020 Coronavirus Pandemic to know about the other issues surrounding reliance on vaccine to resolve the outbreak].

Vaccine development processes have been created to ensure safety. If companies are going to circumvent the process because there is an “emergency”, how can they ensure that they cure will not cause greater damage than the illness? What pushes companies to scramble for the development of a coronavirus vaccine despite its dangers to human life?

Science already shows us that a huge majority of those who are infected with the SARS-COV-2 are likely to recover. Moreover, several researches are already showing that  our own immune system can fight against the virus [see Our Immune System Can Fight Back], which means that if we are generally healthy, our body will take care of the threat naturally.

If vaccines causes one-fifth of recipients to lose capacity for daily activity, and lead them to require medical intervention, why then do we bother spending time and resources for something that cannot guarantee a universal positive result? At this rate of adverse impact, over one billion people will be compromised.

Read Online

Click the button below if you wish to read the article on the website where it was originally published.

Read Offline

Click the button below if you wish to read the article offline.

Leave a Reply

Your email address will not be published. Required fields are marked *